SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Nasr A) "

Sökning: WFRF:(Nasr A)

  • Resultat 1-10 av 66
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Thomas, HS, et al. (författare)
  • 2019
  • swepub:Mat__t
  •  
2.
  •  
3.
  •  
4.
  • Drake, TM, et al. (författare)
  • Surgical site infection after gastrointestinal surgery in children: an international, multicentre, prospective cohort study
  • 2020
  • Ingår i: BMJ global health. - : BMJ. - 2059-7908. ; 5:12
  • Tidskriftsartikel (refereegranskat)abstract
    • Surgical site infection (SSI) is one of the most common healthcare-associated infections (HAIs). However, there is a lack of data available about SSI in children worldwide, especially from low-income and middle-income countries. This study aimed to estimate the incidence of SSI in children and associations between SSI and morbidity across human development settings.MethodsA multicentre, international, prospective, validated cohort study of children aged under 16 years undergoing clean-contaminated, contaminated or dirty gastrointestinal surgery. Any hospital in the world providing paediatric surgery was eligible to contribute data between January and July 2016. The primary outcome was the incidence of SSI by 30 days. Relationships between explanatory variables and SSI were examined using multilevel logistic regression. Countries were stratified into high development, middle development and low development groups using the United Nations Human Development Index (HDI).ResultsOf 1159 children across 181 hospitals in 51 countries, 523 (45·1%) children were from high HDI, 397 (34·2%) from middle HDI and 239 (20·6%) from low HDI countries. The 30-day SSI rate was 6.3% (33/523) in high HDI, 12·8% (51/397) in middle HDI and 24·7% (59/239) in low HDI countries. SSI was associated with higher incidence of 30-day mortality, intervention, organ-space infection and other HAIs, with the highest rates seen in low HDI countries. Median length of stay in patients who had an SSI was longer (7.0 days), compared with 3.0 days in patients who did not have an SSI. Use of laparoscopy was associated with significantly lower SSI rates, even after accounting for HDI.ConclusionThe odds of SSI in children is nearly four times greater in low HDI compared with high HDI countries. Policies to reduce SSI should be prioritised as part of the wider global agenda.
  •  
5.
  •  
6.
  •  
7.
  • Liu, DJ, et al. (författare)
  • Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations
  • 2023
  • Ingår i: Nature genetics. - : Springer Science and Business Media LLC. - 1546-1718 .- 1061-4036. ; 55:3, s. 369-
  • Tidskriftsartikel (refereegranskat)abstract
    • Schizophrenia (SCZ) is a chronic mental illness and among the most debilitating conditions encountered in medical practice. A recent landmark SCZ study of the protein-coding regions of the genome identified a causal role for ten genes and a concentration of rare variant signals in evolutionarily constrained genes1. This recent study—and most other large-scale human genetics studies—was mainly composed of individuals of European (EUR) ancestry, and the generalizability of the findings in non-EUR populations remains unclear. To address this gap, we designed a custom sequencing panel of 161 genes selected based on the current knowledge of SCZ genetics and sequenced a new cohort of 11,580 SCZ cases and 10,555 controls of diverse ancestries. Replicating earlier work, we found that cases carried a significantly higher burden of rare protein-truncating variants (PTVs) among evolutionarily constrained genes (odds ratio = 1.48; P = 5.4 × 10−6). In meta-analyses with existing datasets totaling up to 35,828 cases and 107,877 controls, this excess burden was largely consistent across five ancestral populations. Two genes (SRRM2 and AKAP11) were newly implicated as SCZ risk genes, and one gene (PCLO) was identified as shared by individuals with SCZ and those with autism. Overall, our results lend robust support to the rare allelic spectrum of the genetic architecture of SCZ being conserved across diverse human populations.
  •  
8.
  • Chalmers, J. R., et al. (författare)
  • Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)
  • 2016
  • Ingår i: British Journal of Dermatology. - : Oxford University Press (OUP). - 0007-0963 .- 1365-2133. ; 175:1, s. 69-79
  • Tidskriftsartikel (refereegranskat)abstract
    • This article is a report of the fourth meeting of the Harmonising Outcome Measures for Eczema (HOME) initiative held in Malmo, Sweden on 23-24 April 2015 (HOME IV). The aim of the meeting was to achieve consensus over the preferred outcome instruments for measuring patient-reported symptoms and quality of life for the HOME core outcome set for atopic eczema (AE). Following presentations, which included data from systematic reviews, consensus discussions were held in a mixture of whole group and small group discussions. Small groups were allocated a priori to ensure representation of different stakeholders and countries. Decisions were voted on using electronic keypads. For the patient-reported symptoms, the group agreed by vote that itch, sleep loss, dryness, redness/inflamed skin and irritated skin were all considered essential aspects of AE symptoms. Many instruments for capturing patient-reported symptoms were discussed [ including the Patient-Oriented SCOring Atopic Dermatitis index, Patient-Oriented Eczema Measure (POEM), Self-Administered Eczema Area and Severity Index, Itch Severity Scale, Atopic Dermatitis Quickscore and the Nottingham Eczema Severity Score] and, by consensus, POEM was selected as the preferred instrument to measure patient-reported symptoms. Further work is needed to determine the reliability and measurement error of POEM. Further work is also required to establish the importance of pain/soreness and the importance of collecting information regarding the intensity of symptoms in addition to their frequency. Much of the discussion on quality of life concerned the Dermatology Life Quality Index and Quality of Life Index for Atopic Dermatitis; however, consensus on a preferred instrument for measuring this domain could not be reached. In summary, POEM is recommended as the HOME core outcome instrument for measuring AE symptoms.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 66
Typ av publikation
tidskriftsartikel (49)
konferensbidrag (13)
annan publikation (3)
Typ av innehåll
refereegranskat (50)
övrigt vetenskapligt/konstnärligt (15)
Författare/redaktör
Berzins, Klavs (13)
ElGhazali, Gehad (12)
Nasr, Amre (12)
Giha, Hayder A (9)
Yamazaki, Y. (7)
Nolan, P. (7)
visa fler...
Bertsche, W. (7)
Butler, E. (7)
Cesar, C. L. (7)
Charlton, M. (7)
Fajans, J. (7)
Friesen, T. (7)
Fujiwara, M. C. (7)
Gill, D. R. (7)
Hangst, J. S. (7)
Hardy, W. N. (7)
Jonsell, Svante (7)
Kurchaninov, L. (7)
Madsen, N. (7)
Menary, S. (7)
Olchanski, K. (7)
Povilus, A. (7)
Pusa, P. (7)
Sarid, E. (7)
Silveira, D. M. (7)
So, C. (7)
Thompson, R. I. (7)
Nasr, P (7)
Hagstrom, H (6)
van der Werf, D. P. (6)
Baquero-Ruiz, M. (6)
Hayden, M. E. (6)
Olin, A. (6)
Robicheaux, F. (6)
Wurtele, J. S. (6)
Ekstedt, M (6)
Kumar, S. (5)
Elghazali, G (5)
Noureddin, M (5)
Berzigotti, A (5)
Holleboom, AG (5)
Wong, VWS (5)
Tsochatzis, EA (5)
Trauner, M (5)
Harrison, S (5)
Schmitt, F. (5)
Chan, WK (5)
Kaur, S (5)
Lee, D. (5)
Akbari, C (5)
visa färre...
Lärosäte
Karolinska Institutet (30)
Stockholms universitet (23)
Umeå universitet (7)
Linköpings universitet (6)
Kungliga Tekniska Högskolan (3)
Örebro universitet (3)
visa fler...
Karlstads universitet (3)
Göteborgs universitet (2)
Uppsala universitet (2)
Luleå tekniska universitet (1)
Högskolan i Gävle (1)
Lunds universitet (1)
visa färre...
Språk
Engelska (64)
Odefinierat språk (2)
Forskningsämne (UKÄ/SCB)
Naturvetenskap (18)
Medicin och hälsovetenskap (18)
Teknik (1)
Lantbruksvetenskap (1)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy